Overview

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants

Status:
Recruiting
Trial end date:
2023-03-14
Target enrollment:
Participant gender:
Summary
This is a first time in human study designed to assess the safety, tolerability, pharmacokinetics and PD of GSK3888130B over a range of dose levels in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline